Welcome to our dedicated page for GSI TECHNOLOGY SEC filings (Ticker: GSIT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on GSI TECHNOLOGY's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into GSI TECHNOLOGY's regulatory disclosures and financial reporting.
GSI Technology VP Avidan Akerib reported an exercise-and-sell transaction in company stock. On May 12–13, 2026, he sold a total of 20,000 shares of Common Stock in open-market transactions, including 19,653 shares at a weighted average price of $11.4652 and 347 shares at $12.03 per share.
On the same dates, he exercised stock options covering an aggregate of 20,000 shares of Common Stock at an exercise price of $6.16 per share, converting derivative holdings into common shares. Following these transactions, Akerib directly holds 23,307 shares of GSI Technology common stock.
GSI Technology Senior VP of Memory Design Patrick T. Chuang reported an option exercise and share sale. On May 12, 2026, he exercised options to acquire 40,000 shares of common stock at $6.70 per share, then sold 40,000 shares in an open-market transaction at a weighted average price of $10.6772.
The footnote explains that sale prices ranged from $10.52 to $10.80 per share. After these transactions, Chuang directly owned 15,166 shares of GSI Technology common stock, and the exercised stock option covering 40,000 shares now has no remaining balance.
GSI Technology, Inc. reported an intended sale of Common Stock via an Option Exercise & Sale on 05/13/2026 through Citigroup Global Markets, Inc. The filing lists prior dispositions by Shu Lee-Lean totaling 210,313 shares sold on 03/16/2026, 03/17/2026 and 05/11/2026 with aggregate proceeds shown in the excerpt.
The filing is a Rule 144 notice of an offered sale; it records method (cash) and broker details but does not specify a broader offering size or timing beyond the listed dates.
Avidan Akerib reported Rule 144 sales of GSI Technology common stock. The filing lists an Options Exercise & Sale of 19,653 shares on 05/13/2026 and a separate sale of 347 shares on 05/12/2026 for $4,174.41. The report lists 36,186,203 shares outstanding with a 05/13/2026 anchor.
GSI Technology Inc. president, CEO and chairman Shu Lee-Lean reported an exercise-and-sell sequence in company stock on May 11, 2026. He exercised options for 143,062 shares of common stock at exercise prices of $4.99 and $7.26 per share and sold an equal number of shares in open-market transactions at weighted average prices of about $10.09, $10.51 and $12.01 per share.
Following these transactions, he holds 1,982,417 shares directly and 530,939 shares indirectly through his spouse. Footnotes state that both his sales and his spouse’s sales were carried out under pre-arranged Rule 10b5-1 trading plans.
GSI Technology, Inc. filed a notice under Rule 144 to sell 40,000 shares of Common Stock.
The filing states the method as Option Exercise & Sale on 05/12/2026 with Citigroup Global Markets, Inc. listed as the broker. The excerpt also shows prior dispositions by Patrick T. Chuang of 20,000 shares on 03/02/2026 for $67,310 and 40,000 shares on 03/13/2026 for $342,440.
GSI Technology, Inc. reported a Form 144 notice for proposed sales of Common Stock related to option exercises and subsequent sale on 05/11/2026. The filing lists transactions processed through Citigroup Global Markets, Inc., and prior sales by Shu Lee-Lean on 03/16/2026 and 03/17/2026.
GSI Technology, Inc. reported stronger sales but wider losses for its fourth quarter and fiscal year 2026. Full-year net revenues were $25.1 million, up 22% from fiscal 2025, while gross margin improved to 54.5%. However, higher research and development spending, including work on the Plato chip design, pushed operating expenses to $31.2 million and resulted in a fiscal 2026 net loss of $13.2 million, or $(0.42) per diluted share, unchanged per-share from the prior year.
For the fourth quarter, net revenues were $6.3 million and gross margin was 52.4%, with a net loss of $4.8 million, or $(0.13) per diluted share. As of March 31, 2026, cash and cash equivalents were $67.2 million, up sharply from $13.4 million a year earlier, helped by an October 2025 Registered Direct Offering. Management highlighted over $5.0 million of non-dilutive government funding to date and announced a Phase I smart city deployment and a roughly $2 million U.S. Army SBIR Phase II contract tied to its Gemini-II edge AI platform. Guidance for the first quarter of fiscal 2027 calls for net revenues between $5.9 million and $6.7 million and gross margin of approximately 54% to 56%.
GSI Technology, Inc. reported that its Board of Directors has concluded a previously announced review of strategic alternatives and decided to continue with the Company’s standalone strategy. The Board reached this decision after assessing operational and financial progress and a strengthened balance sheet following an October 2025 capital raise.
GSI Technology plans to focus on commercializing its high-performance memory and compute solutions, advancing key customer programs, and allocating capital carefully toward initiatives intended to support sustainable growth. The Company also highlights risks that its standalone plan and the October 2025 financing may not deliver the anticipated benefits given competitive, market, and execution uncertainties.